Clinical Trials

1 clinical trial matches your search

NCT04127578

Phase 1/2a Open-Label Ascending Dose Study to Evaluate the Safety and Effects of LY3884961 in Patients with Parkinson’s Disease with at Least One GBA1 Mutation (PROPEL)

This study is currently enrolling.

Associated Conditions: Brain Health - Movement Disorders

Research Area: Neuroscience Research

Research Location: Orlando

Parkinson’s disease is a slowly progressive and disabling disease of the central nervous system that causes problems with movement, such as shaking, stiffness, slow movement, and difficulty walking...